Trade Secrets In Court: Are Dissolution Specifications That FDA Gave Vanda Proprietary?

The US Court of Federal Claims expressed concern that Vanda Pharmaceuticals, Inc.’s trade secrets claims against the US Food and Drug Administration could negatively impact the agency’s ability to assist drug manufacturers with their applications, though it allowed some of them to proceed.

Vanda sued FDA last year claiming the agency disclosed trade secret information about its manufacturing processes for Fanapt (iloperidone) and Hetlioz (tasimelteon) to Lupin, Teva, Apotex and to